PBYI vs SPY
Puma Biotechnology Inc (PBYI) versus SPDR S&P 500 ETF Trust (SPY) — a side-by-side from cached financials, not a winner call.
Puma Biotechnology Inc (PBYI) is a biotechnology company listed on US.
SPDR S&P 500 ETF Trust (SPY) common stock listed on US.
Latest reported PBYI revenue for 2026-06-30 was $56.5M. Net income was $8.2M. Revenue was up 26.1% from 2026-03-31 to 2026-06-30. PBYI currently screens at market cap $165.3M and trailing P/E 4.3.
SPY does not have a complete income-statement cache yet.
PBYI currently screens at market cap $165.3M and trailing P/E 4.3. SPY currently screens at market cap $0.
Not investment advice. Open the PBYI and SPY stock pages for the full models.
Not investment advice.